Insulin receptor and cancer

Endocrine-Related Cancer

Volumn 18, Issue 4, 2011, Pages

  Belfiore, Antonino ^a   Malaguarnera, Roberta ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTINEOPLASTIC AGENT; DIPEPTIDYL PEPTIDASE IV INHIBITOR; GLUCOSE TRANSPORTER 4; GROWTH FACTOR RECEPTOR BOUND PROTEIN 2; HEPATOCYTE NUCLEAR FACTOR 3BETA; INSULIN; INSULIN RECEPTOR; METFORMIN; MITOGEN ACTIVATED PROTEIN KINASE; MYC PROTEIN; RECOMBINANT HUMAN INSULIN; SOMATOMEDIN B; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; STAT3 PROTEIN; STEROID RECEPTOR COACTIVATOR 1; SULFONYLUREA DERIVATIVE; TRANSCRIPTION FACTOR ELK 1; TRANSCRIPTION FACTOR PAX6;

BIOAVAILABILITY; BIRTH WEIGHT; CANCER CELL; CANCER GROWTH; CANCER RESISTANCE; CANCER RISK; CANCER THERAPY; CARCINOGENESIS; DIABETES MELLITUS; DISEASE ASSOCIATION; ENZYME SYNTHESIS; EWING SARCOMA; GENE OVEREXPRESSION; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; LUNG NON SMALL CELL CANCER; METABOLIC SYNDROME X; NEOPLASM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PROTEIN EXPRESSION; REVIEW; RISK ASSESSMENT; SIGNAL TRANSDUCTION;

ANIMALS; ANTICARCINOGENIC AGENTS; HUMANS; NEOPLASMS; RECEPTOR, INSULIN;

EID: 80052143150     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1530/ERC-11-0074     Document Type: Review

References (199)

1. Accili D, Drago J, Lee EJ, Johnson MD, Cool MH, Salvatore P, Asico LD, Jose PA, Taylor SI & Westphal H 1996 Early neonatal death in mice homozygous for a null allele of the insulin receptor gene. Nature Genetics 12 106-109. (doi:10.1038/ng0196-106)
2. Aiello A, Pandini G, Frasca F, Conte E, Murabito A, Sacco A, Genua M, Vigneri R & Belfiore A 2006 Peroxisomal proliferator-activated receptor-gamma agonists induce partial reversion of epithelial-mesenchymal transition in anaplastic thyroid cancer cells. Endocrinology 147 4463-4475. (doi:10.1210/en.2005-1610)
3. Alibhai SM, Duong-Hua M, Sutradhar R, Fleshner NE, Warde P, Cheung AM & Paszat LF 2009 Impact of androgen deprivation therapy on cardiovascular disease and diabetes. Journal of Clinical Oncology 27 3452-3458. (doi:10.1200/JCO.2008.20.0923)
4. Alimova IN, Liu B, Fan Z, Edgerton SM, Dillon T, Lind SE & Thor AD 2009 Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro. Cell Cycle 8 909-915. (doi:10.4161/cc.8.6.7933)
5. Avnet S, Sciacca L, Salerno M, Gancitano G, Cassarino MF, Longhi A, Zakikhani M, Carboni JM, Gottardis M, Giunti A et al. 2009 Insulin receptor isoform A and insulin-like growth factor II as additional treatment targets in human osteosarcoma. Cancer Research 69 2443-2452. (doi:10.1158/0008-5472.CAN-08- 2645)
6. Baker J, Liu JP, Robertson EJ & Efstratiadis A 1993 Role of insulin-like growth factors in embryonic and postnatal growth. Cell 75 73-82. (doi:10.1016/S0092-8674(05)80085-6)
7. Barbieri M, Bonafe M, Franceschi C & Paolisso G 2003 Insulin/IGF-I-signaling pathway: an evolutionarily conserved mechanism of longevity from yeast to humans. American Journal of Physiology. Endocrinology and Metabolism 285 E1064-E1071. (doi:10.1152/ajpendo.00296.2003)
8. Baserga R, Hongo A, Rubini M, Prisco M & Valentinis B 1997 The IGF-I receptor in cell growth, transformation and apoptosis. Biochimica et Biophysica Acta 1332 F105-F126. (doi:10.1016/S0304-419X(97)00007-3)
9. Baserga R, Peruzzi F & Reiss K 2003 The IGF-1 receptor in cancer biology. International Journal of Cancer 107 873-877. (doi:10.1002/ijc.11487)
10. Belfiore A 2007 The role of insulin receptor isoforms and hybrid insulin/IGF-I receptors in human cancer. Current Pharmaceutical Design 13 671-686. (doi:10.2174/138161207780249173)
11. Belfiore A, Costantino A, Frasca F, Pandini G, Mineo R, Vigneri P, Maddux B, Goldfine ID & Vigneri R 1996 Overexpression of membrane glycoprotein PC-1 in MDA-MB231 breast cancer cells is associated with inhibition of insulin receptor tyrosine kinase activity. Molecular Endocrinology 10 1318-1326. (doi:10.1210/me.10.11.1318)
12. Belfiore A, Frasca F, Pandini G, Sciacca L & Vigneri R 2009 Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease. Endocrine Reviews 30 586-623. (doi:10.1210/er.2008-0047)
13. Bendall SC, Stewart MH, Menendez P, George D, Vijayaragavan K, Werbowetski-Ogilvie T, Ramos-Mejia V, Rouleau A, Yang J, Bosse M et al. 2007 IGF and FGF cooperatively establish the regulatory stem cell niche of pluripotent human cells in vitro. Nature 448 1015-1021. (doi:10.1038/nature06027)
14. Benecke H, Flier JS & Moller DE 1992 Alternatively spliced variants of the insulin receptor protein. Expression in normal and diabetic human tissues. Journal of Clinical Investigation 89 2066-2070. (doi:10.1172/JCI115819)
15. Benoliel AM, Kahn-Perles B, Imbert J & Verrando P 1997 Insulin stimulates haptotactic migration of human epidermal keratinocytes through activation of NF-kappa B transcription factor. Journal of Cell Science 110 2089-2097. (Pubitemid 27440432)
16. Benyoucef S, Surinya KH, Hadaschik D & Siddle K 2007 Characterization of insulin/IGF hybrid receptors: contributions of the insulin receptor L2 and Fn1 domains and the alternatively spliced exon 11 sequence to ligand binding and receptor activation. Biochemical Journal 403 603-613. (doi:10.1042/BJ20061709)
17. Boucher J, Macotela Y, Bezy O, Mori MA, Kriauciunas K &Kahn CR 2010 A kinase-independent role for unoccupied insulin and IGF-1 receptors in the control of apoptosis. Science Signaling 3 ra87. (doi:10.1126/scisignal.2001173)
18. Bowker SL, Majumdar SR, Veugelers P & Johnson JA 2006 Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin. Diabetes Care 29 254-258. (doi:10.2337/diacare.29.02.06.dc05-1558)
19. Brogiolo W, Stocker H, Ikeya T, Rintelen F, Fernandez R &Hafen E 2001 An evolutionarily conserved function of the Drosophila insulin receptor and insulin-like peptides in growth control. Current Biology 11 213-221. (doi:10.1016/S0960-9822(01)00068-9)
20. Brokaw J, Katsaros D, Wiley A, Lu L, Su D, Sochirca O, de la Longrais IA, Mayne S, Risch H & Yu H 2007 IGF-I in epithelial ovarian cancer and its role in disease progression. Growth Factors 25 346-354. (doi:10.1080/ 08977190701838402)
21. Bruno S, Maisonneuve P, Castellana P, Rotmensz N, Rossi S, Maggioni M, Persico M, Colombo A, Monasterolo F, Casadei-Giunchi D et al. 2005 Incidence and risk factors for non-alcoholic steatohepatitis: prospective study of 5408 women enrolled in Italian tamoxifen chemoprevention trial. BMJ 330 932. (doi:10.1136/bmj.38391.663287.E0)
22. Caceres JF, Stamm S, Helfman DM & Krainer AR 1994 Regulation of alternative splicing in vivo by overexpression of antagonistic splicing factors. Science 265 1706-1709. (doi:10.1126/science.8085156)
23. Calle EE & Kaaks R 2004 Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nature Reviews. Cancer 4 579-591. (doi:10.1038/nrc1408)
24. Cardillo MR, Monti S, Di Silverio F, Gentile V, Sciarra F &Toscano V 2003 Insulin-like growth factor (IGF)-I, IGF-II and IGF type I receptor (IGFR-I) expression in prostatic cancer. Anticancer Research 23 3825-3835.
25. Caughey RW & Michels KB 2009 Birth weight and childhood leukemia: a meta-analysis and review of the current evidence. International Journal of Cancer 124 2658-2670. (doi:10.1002/ijc.24225)
26. Cheng Z, Tseng Y & White MF 2010 Insulin signaling meets mitochondria in metabolism. Trends in Endocrinology and Metabolism 21 589-598. (doi:10.1016/j.tem.2010.06.005)
27. Chong YM, Williams SL, Elkak A, Sharma AK & Mokbel K 2006 Insulin-like growth factor 1 (IGF-1) and its receptor mRNA levels in breast cancer and adjacent non-neoplastic tissue. Anticancer Research 26 167-173. (Pubitemid 43206074)
28. Cohen ND & Hilf R 1974 Influence of insulin on growth and metabolism of 7,12-dimethylbenz(alpha)anthracene-induced mammary tumors. Cancer Research 34 3245-3252.
29. Colhoun HM 2009 Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group. Diabetologia 52 1755-1765. (doi:10.1007/s00125-009-1453-1)
30. Corpet DE, Jacquinet C, Peiffer G & Tache S 1997 Insulin injections promote the growth of aberrant crypt foci in the colon of rats. Nutrition and Cancer 27 316-320. (doi:10.1080/01635589709514543)
31. Costantino A, Milazzo G, Giorgino F, Russo P, Goldfine ID, Vigneri R & Belfiore A 1993 Insulin-resistant MDA-MB231 human breast cancer cells contain a tyrosine kinase inhibiting activity. Molecular Endocrinolgy 7 1667-1676. (doi:10.1210/me.7.12.1667)
32. Coughlin SS, Calle EE, Teras LR, Petrelli J & Thun MJ 2004 Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. American Journal of Epidemiology 159 1160-1167. (doi:10.1093/aje/kwh161)
33. Cox ME, Gleave ME, Zakikhani M, Bell RH, Piura E, Vickers E, Cunningham M, Larsson O, Fazli L &Pollak M 2009 Insulin receptor expression by human prostate cancers. Prostate 69 33-40. (doi:10.1002/pros.20852)
34. Cusi K, Maezono K, Osman A, Pendergrass M, Patti ME, Pratipanawatr T, DeFronzo RA, Kahn CR & Mandarino LJ 2000 Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle. Journal of Clinical Investigation 105 311-320. (doi:10.1172/JCI7535)
35. De Meyts P & Shymko RM 2000 Timing-dependent modulation of insulin mitogenic versus metabolic signalling. Novartis Foundation Symposium 227 46-57 discussion 57-60.
36. Denley A, Carroll JM, Brierley GV, Cosgrove L, Wallace J, Forbes B & Roberts CT Jr 2007 Differential activation of insulin receptor substrates 1 and 2 by insulin-like growth factor-activated insulin receptors. Molecular and Cellular Biology 27 3569-3577. (doi:10.1128/MCB.01447-06)
37. DiGiovanni J, Kiguchi K, Frijhoff A, Wilker E, Bol DK, Beltran L, Moats S, Ramirez A, Jorcano J & Conti C 2000 Deregulated expression of insulin-like growth factor 1 in prostate epithelium leads to neoplasia in transgenic mice. PNAS 97 3455-3460. (doi:10.1073/pnas.97.7.3455)
38. Dombrowski F, Bannasch P & Pfeifer U 1997 Hepatocellular neoplasms induced by low-number pancreatic islet transplants in streptozotocin diabetic rats. American Journal of Pathology 150 1071-1087. (Pubitemid 27106177)
39. Dornhorst A, Nicholls JS, Ali K, Andres C, Adamson DL, Kelly LF, Niththyananthan R, Beard RW & Gray IP 1994 Fetal proinsulin and birth weight. Diabetic Medicine 11 177-181. (doi:10.1111/j.1464-5491.1994.tb02016.x)
40. Drejer K 1992 The bioactivity of insulin analogues from in vitro receptor binding to in vivo glucose uptake. Diabetes/Metabolism Reviews 8 259-285. (doi:10.1002/dmr.5610080305)
41. Duggan C, Irwin ML, Xiao L, Henderson KD, Smith AW, Baumgartner RN, Baumgartner KB, Bernstein L, Ballard-Barbash R & McTiernan A 2011 Associations of insulin resistance and adiponectin with mortality in women with breast cancer. Journal of Clinical Oncology 29 32-39. (doi:10.1200/JCO.2009.26. 4473)
42. Entingh AJ, Taniguchi CM & Kahn CR 2003 Bi-directional regulation of brown fat adipogenesis by the insulin receptor. Journal of Biological Chemistry 278 33377-33383. (doi:10.1074/jbc.M303056200)
43. Evans JM, Donnelly LA, Emslie-Smith AM, Alessi DR &Morris AD 2005 Metformin and reduced risk of cancer in diabetic patients. BMJ 330 1304-1305. (doi:10.1136/bmj.38415.708634.F7)
44. Fair AM, Dai Q, Shu XO, Matthews CE, Yu H, Jin F, Gao YT & Zheng W 2007 Energy balance, insulin resistance biomarkers, and breast cancer risk. Cancer Detection and Prevention 31 214-219. (doi:10.1016/j.cdp.2007.04.003)
45. Feng Y, Zhu Z, Xiao X, Choudhry V, Barrett JC & Dimitrov DS 2006 Novel human monoclonal antibodies to insulin-like growth factor (IGF)-II that potently inhibit the IGF receptor type I signal transduction function. Molecular Cancer Therapeutics 5 114-120. (doi:10.1158/1535-7163.MCT-05-0252)
46. Ferrannini E & Cobelli C 1987 The kinetics of insulin in man. II. Role of the liver. Diabetes/Metabolism Reviews 3 365-397. (doi:10.1002/dmr. 5610030202)
47. Fierz Y, Novosyadlyy R, Vijayakumar A, Yakar S &LeRoith D 2010 Insulin-sensitizing therapy attenuates type 2 diabetes-mediated mammary tumor progression. Diabetes 59 686-693. (doi:10.2337/db09-1291)
48. Fiore E, Campani D, Muller I, Belardi V, Giustarini E, Rossi G, Pinchera A & Giani C 2010 IGF-II mRNA expression in breast cancer: predictive value and relationship to other prognostic factors. International Journal of Biological Markers 25 150-156.
49. Frasca F, Pandini G, Scalia P, Sciacca L, Mineo R, Costantino A, Goldfine ID, Belfiore A & Vigneri R 1999 Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells. Molecular and Cellular Biology 19 3278-3288. (Pubitemid 29193789)
50. Frasca F, Pandini G, Malaguarnera R, Mandarino A, Messina RL, Sciacca L, Belfiore A & Vigneri R 2007 Role of c-Abl in directing metabolic versus mitogenic effects in insulin receptor signaling. Journal of Biological Chemistry 282 26077-26088. (doi:10.1074/jbc.M705008200)
51. Freier S, Weiss O, Eran M, Flyvbjerg A, Dahan R, Nephesh I, Safra T, Shiloni E & Raz I 1999 Expression of the insulin-like growth factors and their receptors in adenocarcinoma of the colon. Gut 44 704-708. (doi:10.1136/gut.44.5.704)
52. Frystyk J 2004 Free insulin-like growth factors - measurements and relationships to growth hormone secretion and glucose homeostasis. Growth Hormone & IGF Research 14 337-375. (doi:10.1016/j.ghir.2004.06.001)
53. Fulzele K, DiGirolamo DJ, Liu Z, Xu J, Messina JL &Clemens TL 2007 Disruption of the insulin-like growth factor type 1 receptor in osteoblasts enhances insulin signaling and action. Journal of Biological Chemistry 282 25649-25658. (doi:10.1074/jbc.M700651200)
54. Gao J, Chesebrough JW, Cartlidge SA, Ricketts SA, Incognito L, Veldman-Jones M, Blakey DC, Tabrizi M, Jallal B, Trail PA et al. 2011 Dual IGF-I/II-neutralizing antibody MEDI-573 potently inhibits IGF signaling and tumor growth. Cancer Research 71 1029-1040. (doi:10.1158/0008-5472.CAN-10-2274)
55. Garofalo C, Manara MC, Nicoletti G, Marino MT, Lollini PL, Astolfi A, Pandini G, Lopez-Guerrero JA, Schaefer KL, Belfiore A et al. 2011 Efficacy of and resistance to anti-IGF-1R therapies in Ewing's sarcoma is dependent on insulin receptor signaling. Oncogene [in press] . (doi:10.1038/onc.2010.640)
56. Gebauer G, Jager W & Lang N 1998 mRNA expression of components of the insulin-like growth factor system in breast cancer cell lines, tissues, and metastatic breast cancer cells. Anticancer Research 18 1191-1195. (Pubitemid 28239662)
57. Gicquel C, Bertagna X, Gaston V, Coste J, Louvel A, Baudin E, Bertherat J, Chapuis Y, Duclos JM, Schlumberger M et al. 2001 Molecular markers and long-term recurrences in a large cohort of patients with sporadic adrenocortical tumors. Cancer Research 61 6762-6767. (Pubitemid 32896498)
58. Giddings SJ & Carnaghi LR 1992 Insulin receptor gene expression during development: developmental regulation of insulin receptor mRNA abundance in embryonic rat liver and yolk sac, developmental regulation of insulin receptor gene splicing, and comparison to abundance of insulin-like growth factor 1 receptor mRNA. Molecular Endocrinolgy 6 1665-1672. (doi:10.1210/me.6. 10.1665)
59. Giorgino F, Belfiore A, Milazzo G, Costantino A, Maddux B, Whittaker J, Goldfine ID & Vigneri R 1991 Overexpression of insulin receptors in fibroblast and ovary cells induces a ligand-mediated transformed phenotype. Molecular Endocrinolgy 5 452-459. (doi:10.1210/mend-5-3-452)
60. Giudice J, Leskow FC, Arndt-Jovin DJ, Jovin TM &Jares-Erijman EA 2011 Differential endocytosis and signaling dynamics of insulin receptor variants IR-A and IR-B. Journal of Cell Science 124 801-811. (doi:10.1242/jcs.076869)
61. Goalstone M, Carel K, Leitner JW & Draznin B 1997 Insulin stimulates the phosphorylation and activity of farnesyltransferase via the Ras-mitogen-activated protein kinase pathway. Endocrinology 138 5119-5124. (doi:10.1210/en.138.12.5119)
62. Govindarajan R, Ratnasinghe L, Simmons DL, Siegel ER, Midathada MV, Kim L, Kim PJ, Owens RJ & Lang NP 2007 Thiazolidinediones and the risk of lung, prostate, and colon cancer in patients with diabetes. Journal of Clinical Oncology 25 1476-1481. (doi:10.1200/JCO.2006.07.2777)
63. Gual P, Le Marchand-Brustel Y & Tanti JF 2005 Positive and negative regulation of insulin signaling through IRS-1 phosphorylation. Biochimie 87 99-109. (doi:10.1016/j.biochi.2004.10.019)
64. Gunter MJ, Hoover DR, Yu H, Wassertheil-Smoller S, Rohan TE, Manson JE, Li J, Ho GY, Xue X, Anderson GL et al. 2009 Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women. Journal of National Cancer Institute 101 48-60. (doi:10.1093/jnci/djn415)
65. Hakam A, Yeatman TJ, Lu L, Mora L, Marcet G, Nicosia SV, Karl RC & Coppola D 1999 Expression of insulin-like growth factor-1 receptor in human colorectal cancer. Human Pathology 30 1128-1133. (doi:10.1016/S0046-8177(99) 90027-8)
66. Haluska P, Carboni JM, Loegering DA, Lee FY, Wittman M, Saulnier MG, Frennesson DB, Kalli KR, Conover CA, Attar RM et al. 2006 In vitro and in vivo antitumor effects of the dual insulin-like growth factor-I/insulin receptor inhibitor, BMS-554417. Cancer Research 66 362-371. (doi:10.1158/0008-5472.CAN- 05-1107)
67. Hawley SA, Boudeau J, Reid JL, Mustard KJ, Udd L, Makela TP, Alessi DR & Hardie DG 2003 Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade. Journal of Biology 2 28. (doi:10.1186/1475-4924-2-28)
68. Hemkens LG, Grouven U, Bender R, Gunster C, Gutschmidt S, Selke GW & Sawicki PT 2009 Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study. Diabetologia 52 1732-1744. (doi:10.1007/s00125-009-1418-4)
69. Heuson JC & Legros N 1972 Influence of insulin deprivation on growth of the 7,12-dimethylbenz(a)anthracene-induced mammary carcinoma in rats subjected to alloxan diabetes and food restriction. Cancer Research 32 226-232.
70. Heuson JC, Legros N & Heimann R 1972 Influence of insulin administration on growth of the 7,12-dimethylbenz(a)anthracene- induced mammary carcinoma in intact, oophorectomized, and hypophysectomized rats. Cancer Research 32 233-238.
71. Hofmann F & Garcia-Echeverria C 2005 Blocking the insulin-like growth factor-I receptor as a strategy for targeting cancer. Drug Discovery Today 10 1041-1047. (doi:10.1016/S1359-6446(05)03512-9)
72. Holland EC, Sonenberg N, Pandolfi PP & Thomas G 2004 Signaling control of mRNA translation in cancer pathogenesis. Oncogene 23 3138-3144. (doi:10.1038/sj.onc.1207590)
73. Huff KK, Kaufman D, Gabbay KH, Spencer EM, Lippman ME & Dickson RB 1986 Secretion of an insulin-like growth factor-I-related protein by human breast cancer cells. Cancer Research 46 4613-4619. (Pubitemid 16000334)
74. Irwin ML, Duggan C, Wang CY, Smith AW, McTiernan A, Baumgartner RN, Baumgartner KB, Bernstein L &Ballard-Barbash R 2011 Fasting C-peptide levels and death resulting fromall causes and breast cancer: the health, eating, activity, and lifestyle study. Journal of Clinical Oncology 29 47-53. (doi:10.1200/JCO.2010.28.4752)
75. Ish-Shalom D, Christoffersen CT, Vorwerk P, Sacerdoti-Sierra N, Shymko RM, Naor D & De Meyts P 1997 Mitogenic properties of insulin and insulin analogues mediated by the insulin receptor. Diabetologia 40 (Suppl 2) S25-S31. (doi:10.1007/s001250051393)
76. Jehle PM, Fussgaenger RD, Blum WF, Angelus NK, Hoeflich A, Wolf E & Jungwirth RJ 1999 Differential autocrine regulation of intestine epithelial cell proliferation and differentiation by insulin-like growth factor (IGF) system components. Hormone and Metabolic Research 31 97-102. (doi:10.1055/s-2007- 978705)
77. Jensen M, Hansen B, De Meyts P, Schaffer L & Urso B 2007 Activation of the insulin receptor by insulin and a synthetic peptide leads to divergent metabolic and mitogenic signaling and responses. Journal of Biological Chemistry 282 35179-35186. (doi:10.1074/jbc.M704599200)
78. Jiang ZY, Lin YW, Clemont A, Feener EP, Hein KD, Igarashi M, Yamauchi T, White MF & King GL 1999 Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats. Journal of Clinical Investigation 104 447-457. (doi:10.1172/JCI5971)
79. Jiracek J, Zakova L, Antolikova E, Watson CJ, Turkenburg JP, Dodson GG & Brzozowski AM 2010 Implications for the active form of human insulin based on the structural convergence of highly active hormone analogues. PNAS 107 1966-1970. (doi:10.1073/pnas.0911785107)
80. Johnson JA, Majumdar SR, Simpson SH & Toth EL 2002 Decreased mortality associated with the use of metformin compared with sulfonylurea monotherapy in type 2 diabetes. Diabetes Care 25 2244-2248. (doi:10.2337/ diacare.25.12.2244)
81. Jones HE, Gee JM, Barrow D, Tonge D, Holloway B &Nicholson RI 2006 Inhibition of insulin receptor isoform-A signalling restores sensitivity to gefitinib in previously de novo resistant colon cancer cells. British Journal of Cancer 95 172-180. (doi:10.1038/sj.bjc.6603237)
82. Kaaks R & Lukanova A 2002 Effects of weight control and physical activity in cancer prevention: role of endogenous hormone metabolism. Annals of the New York Academy of Sciences 963 268-281. (doi:10.1111/j.1749-6632.2002. tb04118.x)
83. Kabat GC, Kim M, Caan BJ, Chlebowski RT, Gunter MJ, Ho GY, Rodriguez BL, Shikany JM, Strickler HD, Vitolins MZ et al. 2009 Repeated measures of serum glucose and insulin in relation to postmenopausal breast cancer. International Journal of Cancer 125 2704-2710. (doi:10.1002/ijc.24609)
84. Kalli KR, Falowo OI, Bale LK, Zschunke MA, Roche PC &Conover CA 2002 Functional insulin receptors on human epithelial ovarian carcinoma cells: implications for IGF-II mitogenic signaling. Endocrinology 143 3259-3267. (doi:10.1210/en.2001-211408)
85. Kaplan SA 1984 The insulin receptor. Journal of Pediatrics 104 327-336. (doi:10.1016/S0022-3476(84)81090-2)
86. Kawamoto K, Onodera H, Kondo S, Kan S, Ikeuchi D, Maetani S & Imamura M 1998 Expression of insulin-like growth factor-2 can predict the prognosis of human colorectal cancer patients: correlation with tumor progression, proliferative activity and survival. Oncology 55 242-248. (doi:10.1159/ 000011858)
87. Keating NL, O'Malley AJ, Freedland SJ & Smith MR 2010 Diabetes and cardiovascular disease during androgen deprivation therapy: observational study of veterans with prostate cancer. Journal of National Cancer Institute 102 39-46. (doi:10.1093/jnci/djp404)
88. Kitamura T, Kahn CR & Accili D 2003 Insulin receptor knockout mice. Annual Review of Physiology 65 313-332. (doi:10.1146/annurev.physiol.65.092101. 142540)
89. Kosaki A & Webster NJ 1993 Effect of dexamethasone on the alternative splicing of the insulin receptor mRNA and insulin action in HepG2 hepatoma cells. Journal of Biological Chemistry 268 21990-21996. (Pubitemid 23320706)
90. Kosaki A, Pillay TS, Xu L & Webster NJ 1995 The B isoform of the insulin receptor signals more efficiently than the A isoform in HepG2 cells. Journal of Biological Chemistry 270 20816-20823. (doi:10.1074/jbc.270.35.20816)
91. Kulkarni RN, Bruning JC, Winnay JN, Postic C, Magnuson MA & Kahn CR 1999 Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes. Cell 96 329-339. (doi:10.1016/S0092-8674(00)80546-2)
92. Kurtzhals P, Schaffer L, Sorensen A, Kristensen C, Jonassen I, Schmid C & Trub T 2000 Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use. Diabetes 49 999-1005. (doi:10.2337/diabetes.49.6.999)
93. Lambert S, Vivario J, Boniver J & Gol-Winkler R 1990 Abnormal expression and structural modification of the insulin-like growth-factor-II gene in human colorectal tumors. International Journal of Cancer 46 405-410. (doi:10.1002/ijc.2910460313)
94. Law JH, Habibi G, Hu K, Masoudi H, Wang MY, Stratford AL, Park E, Gee JM, Finlay P, Jones HE et al. 2008 Phosphorylated insulin-like growth factor-i/insulin receptor is present in all breast cancer subtypes and is related to poor survival. Cancer Research 68 10238-10246. (doi:10.1158/0008- 5472.CAN-08-2755)
95. Leibiger B, Leibiger IB, Moede T, Kemper S, Kulkarni RN, Kahn CR, de Vargas LM & Berggren PO 2001 Selective insulin signaling through A and B insulin receptors regulates transcription of insulin and glucokinase genes in pancreatic beta cells. Molecular Cell 7 559-570. (doi:10.1016/S1097-2765(01) 00203-9)
96. Li SL, Goko H, Xu ZD, Kimura G, Sun Y, Kawachi MH, Wilson TG, Wilczynski S & Fujita-Yamaguchi Y 1998 Expression of insulin-like growth factor (IGF)-II in human prostate, breast, bladder, and paraganglioma tumors. Cell Tissue Research 291 469-479. (doi:10.1007/s004410051016)
97. Li SR, Ng CF, Banerjea A, Ahmed S, Hands R, Powar M, Ogunkolade W, Dorudi S & Bustin SA 2004 Differential expression patterns of the insulin-like growth factor 2 gene in human colorectal cancer. Tumour Biology 25 62-68. (doi:10.1159/000077725)
98. Liang J & Slingerland JM 2003 Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progression. Cell Cycle 2 339-345. (doi:10.4161/cc.2.4. 433)
99. Liao Y, Abel U, Grobholz R, Hermani A, Trojan L, Angel P & Mayer D 2005 Up-regulation of insulin-like growth factor axis components in human primary prostate cancer correlates with tumor grade. Human Pathology 36 1186-1196. (doi:10.1016/j.humpath.2005.07.023)
100. Liu JP, Baker J, Perkins AS, Robertson EJ & Efstratiadis A 1993 Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 75 59-72. (doi:10.1016/S0092- 8674(05)80084-4)
101. Louvi A, Accili D & Efstratiadis A 1997 Growth-promoting interaction of IGF-II with the insulin receptor during mouse embryonic development. Developmental Biology 189 33-48. (doi:10.1006/dbio.1997.8666)
102. Maiorano E, Ciampolillo A, Viale G, Maisonneuve P, Ambrosi A, Triggiani V, Marra E & Perlino E 2000 Insulin-like growth factor 1 expression in thyroid tumors. Applied Immunohistochemistry & Molecular Morphology 8 110-119. (doi:10.1097/00022744-200006000-00005)
103. Malaguarnera R, Frasca F, Garozzo A, Giani F, Pandini G, Vella V, Vigneri R & Belfiore A 2011 Insulin receptor isoforms and insulin-like growth factor receptor in human follicular cell precursors from papillary thyroid cancer and normal thyroid. Journal of Clinical Endocrinology and Metabolism 96 766-774. (doi:10.1210/jc.2010-1255)
104. Mastick CC, Kato H, Roberts CT Jr, LeRoith D & Saltiel AR 1994 Insulin and insulin-like growth factor-I receptors similarly stimulate deoxyribonucleic acid synthesis despite differences in cellular protein tyrosine phosphorylation. Endocrinology 135 214-222. (doi:10.1210/en.135.1.214)
105. Mathieu MC, Clark GM, Allred DC, Goldfine ID & Vigneri R 1997 Insulin receptor expression and clinical outcome in node-negative breast cancer. Proceedings of the Association of American Physicians 109 565-571. (Pubitemid 27495695)
106. Mayer D, Shukla A & Enzmann H 2008 Proliferative effects of insulin analogues on mammary epithelial cells. Archives of Physiology and Biochemistry 114 38-44. (doi:10.1080/13813450801900645)
107. McCarty MF 2004 Chronic activation of AMP-activated kinase as a strategy for slowing aging. Medical Hypotheses 63 334-339. (doi:10.1016/j.mehy.2004.01. 043)
108. McDevitt TC, Laflamme MA & Murry CE 2005 Proliferation of cardiomyocytes derived from human embryonic stem cells is mediated via the IGF/PI 3-kinase/Akt signaling pathway. Journal of Molecular and Cellular Cardiology 39 865-873. (doi:10.1016/j.yjmcc.2005.09.007)
109. Michell NP, Langman MJ & Eggo MC 1997 Insulin-like growth factors and their binding proteins in human colonocytes: preferential degradation of insulin-like growth factor binding protein 2 in colonic cancers. British Journal of Cancer 76 60-66. (doi:10.1038/bjc.1997.337)
110. Michos A, Xue F & Michels KB 2007 Birth weight and the risk of testicular cancer: a meta-analysis. International Journal of Cancer 121 1123-1131. (doi:10.1002/ijc.22771)
111. Milazzo G, Giorgino F, Damante G, Sung C, Stampfer MR, Vigneri R, Goldfine ID & Belfiore A 1992 Insulin receptor expression and function in human breast cancer cell lines. Cancer Research 52 3924-3930.
112. Miyamoto S, Nakamura M, Shitara K, Nakamura K, Ohki Y, Ishii G, Goya M, Kodama K, Sangai T, Maeda H et al. 2005 Blockade of paracrine supply of insulin-like growth factors using neutralizing antibodies suppresses the liver metastasis of human colorectal cancers. Clinical Cancer Research 11 3494-3502. (doi:10.1158/1078-0432.CCR-04-1701)
113. Mochizuki S, Yoshida S, Yamanaka Y, Matsuo H & Maruo T2005 Effects of estriol on proliferative activity and expression of insulin-like growth factor-I (IGF-I) and IGF-I receptor mRNA in cultured human osteoblast-like osteosarcoma cells. Gynecological Endocrinology 20 6-12. (doi:10.1080/ 09513590400020831)
114. Moller DE, Yokota A, Caro JF & Flier JS 1989 Tissue-specific expression of two alternatively spliced insulin receptor mRNAs in man. Molecular Endocrinolgy 3 1263-1269. (doi:10.1210/mend-3-8-1263)
115. Monami M, Balzi D, Lamanna C, Barchielli A, Masotti G, Buiatti E, Marchionni N & Mannucci E 2007 Are sulphonylureas all the same? A cohort study on cardiovascular and cancer-related mortality Diabetes/Metabolism Research and Reviews 23 479-484. (doi:10.1002/dmrr.736)
116. Monami M, Lamanna C, Marchionni N & Mannucci E 2008 Rosiglitazone and risk of cancer: a meta-analysis of randomized clinical trials. Diabetes Care 31 1455-1460. (doi:10.2337/dc07-2308)
117. Monami M, Lamanna C, Balzi D, Marchionni N & Mannucci E 2009 Sulphonylureas and cancer: a case-control study. Acta Diabetologia 46 279-284. (doi:10.1007/s00592-008-0083-2)
118. Morales AV, Serna J, Alarcon C, de la Rosa EJ & de Pablo F 1997 Role of prepancreatic (pro)insulin and the insulin receptor in prevention of embryonic apoptosis. Endocrinology 138 3967-3975. (doi:10.1210/en.138.9.3967)
119. Morcavallo A, Gaspari M, Pandini G, Palummo A, Cuda G, Larsen MR, Vigneri R & Belfiore A 2011 New and diverse substrates for the insulin receptor isoform A revealed by quantitative proteomics after stimulation with IGF-II or insulin. Molecular Endocrinology [in press]. (doi:10.1210/me.2010-0484)
120. Moro-Sibilot D, Coudurier M & Lantuejoul S 2010 Targeting insulin-like growth factors in the treatment of cancer. Revue des Maladies Respiratoires 27 959-963. (doi:10.1016/j.rmr.2010.07.005)
121. Mu L, Katsaros D, Wiley A, Lu L, de la Longrais IA, Smith S, Khubchandani S, Sochirca O, Arisio R & Yu H 2009 Peptide concentrations and mRNA expression of IGF-I, IGF-II and IGFBP-3 in breast cancer and their associations with disease characteristics. Breast Cancer Research and Treatment 115 151-162. (doi:10.1007/s10549-008-0046-x)
122. Mulholland DJ, Dedhar S, Coetzee GA & Nelson CC 2005 Interaction of nuclear receptors with the Wnt/beta-catenin/Tcf signaling axis: Wnt you like to know? Endocrine Reviews 26 898-915. (doi:10.1210/er.2003-0034)
123. Mur C, Valverde AM, Kahn CR & Benito M 2002 Increased insulin sensitivity in IGF-I receptor - deficient brown adipocytes. Diabetes 51 743-754. (doi:10.2337/diabetes.51.3.743)
124. Nakae J, Kido Y & Accili D 2001 Distinct and overlapping functions of insulin and IGF-I receptors. Endocrine Reviews 22 818-835. (doi:10.1210/er.22. 6.818)
125. Nickerson T, Chang F, Lorimer D, Smeekens SP, Sawyers CL & Pollak M 2001 In vivo progression of LAPC-9 and LNCaP prostate cancer models to androgen independence is associated with increased expression of insulin-like growth factor I (IGF-I) and IGF-I receptor (IGF-IR). Cancer Research 61 6276-6280.
126. Novosyadlyy R, Lann DE, Vijayakumar A, Rowzee A, Lazzarino DA, Fierz Y, Carboni JM, Gottardis MM, Pennisi PA, Molinolo AA et al. 2010 Insulin-mediated acceleration of breast cancer development and progression in a nonobese model of type 2 diabetes. Cancer Research 70 741-751. (doi:10.1158/0008-5472.CAN-09- 2141)
127. Okamoto H, Nakae J, Kitamura T, Park BC, Dragatsis I &Accili D 2004 Transgenic rescue of insulin receptor-deficient mice. Journal of Clinical Investigation 114 214-223. (doi:10.1172/JCI21645)
128. Osborne CK, Monaco ME, Lippman ME & Kahn CR 1978 Correlation among insulin binding, degradation, and biological activity in human breast cancer cells in long-term tissue culture. Cancer Research 38 94-102. (Pubitemid 8253520)
129. Paik S 1992 Expression of IGF-I and IGF-II mRNA in breast tissue. Breast Cancer Research and Treatment 22 31-38. (doi:10.1007/BF01833331)
130. Pandini G, Frasca F, Mineo R, Sciacca L, Vigneri R &Belfiore A 2002 Insulin/insulin-like growth factor I hybrid receptors have different biological characteristics depending on the insulin receptor isoform involved. Journal of Biological Chemistry 277 39684-39695. (doi:10.1074/jbc.M202766200)
131. Pandini G, Medico E, Conte E, Sciacca L, Vigneri R &Belfiore A 2003 Differential gene expression induced by insulin and insulin-like growth factor-II through the insulin receptor isoform A. Journal of Biological Chemistry 278 42178-42189. (doi:10.1074/jbc.M304980200)
132. Papa V, Pezzino V, Costantino A, Belfiore A, Giuffrida D, Frittitta L, Vannelli GB, Brand R, Goldfine ID & Vigneri R 1990 Elevated insulin receptor content in human breast cancer. Journal of Clinical Investigation 86 1503-1510. (doi:10.1172/JCI114868)
133. Papa V, Costantino A & Belfiore A 1997 Insulin receptor what role in breast cancer? Trends in Endocrinology and Metabolism 8 306-312. (doi:10.1016/S1043-2760(97)00114-8)
134. Park SK, Kang D, McGlynn KA, Garcia-Closas M, Kim Y, Yoo KY & Brinton LA 2008 Intrauterine environments and breast cancer risk: meta-analysis and systematic review. Breast Cancer Research 10 R8. (doi:10.1186/bcr1850)
135. Pezzino V, Papa V, Trischitta V, Brunetti A, Goodman PA, Treutelaar MK, Williams JA, Maddux BA, Vigneri R &Goldfine ID 1989 Human insulin receptor radioimmunoassay: applicability to insulin-resistant states. American Journal of Physiology 257 E451-E457.
136. Pietrzkowski Z, Mulholland G, Gomella L, Jameson BA, Wernicke D & Baserga R 1993 Inhibition of growth of prostatic cancer cell lines by peptide analogues of insulin-like growth factor 1. Cancer Research 53 1102-1106. (Pubitemid 23087914)
137. Pillemer G, Lugasi-Evgi H, Scharovsky G & Naor D 1992 Insulin dependence of murine lymphoid T-cell leukemia. International Journal of Cancer 50 80-85. (doi:10.1002/ijc.2910500117)
138. Pisani P 2008 Hyper-insulinaemia and cancer, meta-analyses of epidemiological studies. Archives of Physiology and Biochemistry 114 63-70. (doi:10.1080/13813450801954451)
139. Pollak MN, Schernhammer ES & Hankinson SE 2004 Insulin-like growth factors and neoplasia. Nature Reviews. Cancer 4 505-518. (doi:10.1038/nrc1387)
140. Ramos-Nino ME, MacLean CD & Littenberg B 2007 Association between cancer prevalence and use of thiazolidinediones: results from the Vermont Diabetes Information System. BMC Medicine 5 17. (doi:10.1186/1741-7015-5-17)
141. Rasmussen AA & Cullen KJ 1998 Paracrine/autocrine regulation of breast cancer by the insulin-like growth factors. Breast Cancer Research and Treatment 47 219-233. (doi:10.1023/A:1005903000777)
142. Redig AJ & Munshi HG 2010 Care of the cancer survivor: metabolic syndrome after hormone-modifying therapy. American Journal of Medicine 123 e1-e6. (doi:10.1016/j.amjmed.2009.06.022)
143. Rose PP, Carroll JM, Carroll PA, DeFilippis VR, LagunoffM, Moses AV, Roberts CT Jr & Fruh K 2007 The insulin receptor is essential for virus-induced tumorigenesis of Kaposi's sarcoma. Oncogene 26 1995-2005. (doi:10.1038/sj.onc.1210006)
144. Rousseau MC, Parent ME, Pollak MN & Siemiatycki J 2006 Diabetes mellitus and cancer risk in a population-based case-control study among men from Montreal, Canada. International Journal of Cancer 118 2105-2109. (doi:10.1002/ijc.21600)
145. Rubin R, Arzumanyan A, Soliera AR, Ross B, Peruzzi F &PriscoM2007 Insulin receptor substrate (IRS)-1 regulates murine embryonic stem (mES) cells self-renewal. Journal of Cell Physiology 213 445-453. (doi:10.1002/jcp.21185)
146. Ruderman N&PrentkiM2004AMPkinase and malonyl-CoA: targets for therapy of the metabolic syndrome. Nature Reviews. Drug Discovery 3 340-351. (doi:10.1038/nrd1344)
147. Sacco A, Morcavallo A, Pandini G, Vigneri R & Belfiore A 2009 Differential signaling activation by insulin and insulin-like growth factors I and II upon binding to insulin receptor isoform A. Endocrinology 150 3594-3602. (doi:10.1210/en.2009-0377)
148. Samani AA, Yakar S, LeRoith D & Brodt P 2007 The role of the IGF system in cancer growth and metastasis: overview and recent insights. Endocrine Reviews 28 20-47. (doi:10.1210/er.2006-0001)
149. Sandhu MS, Dunger DB & Giovannucci EL 2002 Insulin, insulin-like growth factor-I (IGF-I), IGF binding proteins, their biologic interactions, and colorectal cancer. Journal of National Cancer Institute 94 972-980. (doi:10.1093/jnci/94.13.972)
150. Savarese TM, Strohsnitter WC, Low HP, Liu Q, Baik I, Okulicz W, Chelmow DP, Lagiou P, Quesenberry PJ, Noller KL et al. 2007 Correlation of umbilical cord blood hormones and growth factors with stem cell potential: implications for the prenatal origin of breast cancer hypothesis. Breast Cancer Research 9 R29. (doi:10.1186/bcr1674)
151. Sayer RA, Lancaster JM, Pittman J, Gray J, Whitaker R, Marks JR & Berchuck A 2005 High insulin-like growth factor-2 (IGF-2) gene expression is an independent predictor of poor survival for patients with advanced stage serous epithelial ovarian cancer. Gynecologic Oncology 96 355-361. (doi:10.1016/j. ygyno.2004.10.012)
152. Schneider MB, Matsuzaki H, Haorah J, Ulrich A, Standop J, Ding XZ, Adrian TE & Pour PM 2001 Prevention of pancreatic cancer induction in hamsters by metformin. Gastroenterology 120 1263-1270. (doi:10.1053/gast.2001.23258)
153. Sciacca L, Costantino A, Pandini G, Mineo R, Frasca F, Scalia P, Sbraccia P, Goldfine ID, Vigneri R & Belfiore A 1999 Insulin receptor activation by IGF-II in breast cancers: evidence for a new autocrine/paracrine mechanism. Oncogene 18 2471-2479. (doi:10.1038/sj.onc.1202600)
154. Sciacca L, Mineo R, Pandini G, Murabito A, Vigneri R &Belfiore A 2002 In IGF-I receptor-deficient leiomyosarcoma cells autocrine IGF-II induces cell invasion and protection from apoptosis via the insulin receptor isoform A. Oncogene 21 8240-8250. (doi:10.1038/sj.onc.1206058)
155. Sciacca L, Prisco M, Wu A, Belfiore A, Vigneri R & Baserga R 2003 Signaling differences from the A and B isoforms of the insulin receptor (IR) in 32D cells in the presence or absence of IR substrate-1. Endocrinology 144 2650-2658. (doi:10.1210/en.2002-0136)
156. Scotlandi K 2006 Targeted therapies in Ewing's sarcoma. Advances in Experimental Medicine and Biology 587 13-22. (doi:10.1007/978-1-4020-5133-3-2)
157. Scotlandi K, Manara MC, Serra M, Marino MT, Ventura S, Garofalo C, Alberghini M, Magagnoli G, Ferrari S, Lopez-Guerrero JA et al. 2011 Expression of insulin-like growth factor system components in Ewing's sarcoma and their association with survival. European Journal of Cancer 47 1258-1266. (doi:10.1016/j.ejca.2011.01.007)
158. Seino S & Bell GI 1989 Alternative splicing of human insulin receptor messenger RNA. Biochemical and Biophysical Research Communications 159 312-316. (doi:10.1016/0006-291X(89)92439-X)
159. Shafie SM & Grantham FH 1981 Role of hormones in the growth and regression of human breast cancer cells (MCF-7) transplanted into athymic nude mice. Journal of National Cancer Institute 67 51-56.
160. Sharon R, Pillemer G, Ish-Shalom D, Kalman R, Ziv E, Berry EM & Naor D 1993 Insulin dependence of murine T-cell lymphoma. II. Insulin-deficient diabetic mice and mice fed low-energy diet develop resistance to lymphoma growth. International Journal of Cancer 53 843-849. (doi:10.1002/ijc.2910530523)
161. Shin A, Ren Z, Shu XO, Cai Q, Gao YT & Zheng W 2007 Expression patterns of insulin-like growth factor 1 (IGF-I) and its receptor in mammary tissues and their associations with breast cancer survival. Breast Cancer Research and Treatment 105 55-61. (doi:10.1007/s10549-006-9427-1)
162. Singh P, Dai B, Yallampalli C & Xu Z 1994 Expression of IGF-II and IGF-binding proteins by colon cancer cells in relation to growth response to IGFs. American Journal of Physiology 267 G608-G617.
163. Smith JC, Bennett S, Evans LM, Kynaston HG, Parmar M, Mason MD, Cockcroft JR, Scanlon MF & Davies JS 2001 The effects of induced hypogonadism on arterial stiffness, body composition, and metabolic parameters in males with prostate cancer. Journal of Clinical Endocrinology and Metabolism 86 4261-4267. (doi:10.1210/jc.86.9.4261)
164. Smith MR, Finkelstein JS, McGovern FJ, Zietman AL, Fallon MA, SchoenfeldDA&Kantoff PW2002Changes in body composition during androgen deprivation therapy for prostate cancer. Journal of Clinical Endocrinology and Metabolism 87 599-603. (doi:10.1210/jc.87.2.599)
165. Solomon CS & Goalstone ML 2001 Dominant negative farnesyltransferase alpha-subunit inhibits insulin mitogenic effects. Biochemical and Biophysical Research Communications 285 161-166. (doi:10.1006/bbrc.2001.5142)
166. Sommerfeld MR, Muller G, Tschank G, Seipke G, Habermann P, Kurrle R & Tennagels N 2010 In vitro metabolic and mitogenic signaling of insulin glargine and its metabolites. PLoS ONE 5 e9540. (doi:10.1371/journal.pone.0009540)
167. Stachelscheid H, Ibrahim H, Koch L, Schmitz A, Tscharntke M, Wunderlich FT, Scott J, Michels C, Wickenhauser C, Haase I et al. 2008 Epidermal insulin/IGF-1 signalling control interfollicular morphogenesis and proliferative potential through Rac activation. EMBO Journal 27 2091-2101. (doi:10.1038/emboj.2008.141)
168. Stammberger I, Seipke G & Bartels T 2006 Insulin glulisine - a comprehensive preclinical evaluation. International Journal of Toxicology 25 25-33. (doi:10.1080/10915810500488379)
169. Standaert ML, Schimmel SD & Pollet RJ 1984 The development of insulin receptors and responses in the differentiating nonfusing muscle cell line BC3H-1. Journal of Biological Chemistry 259 2337-2345. (Pubitemid 14190351)
170. Strammiello R, Benini S, Manara MC, Perdichizzi S, Serra M, Spisni E, Picci P & Scotlandi K 2003 Impact of IGF-I/IGF-IR circuit on the angiogenetic properties of Ewing's sarcoma cells. Hormone and Metabolic Research 35 675-684. (doi:10.1055/s-2004-814149)
171. Strickler HD, Wylie-Rosett J, Rohan T, Hoover DR, Smoller S, Burk RD & Yu H 2001 The relation of type 2 diabetes and cancer. Diabetes Technology & Therapeutics 3 263-274. (doi:10.1089/152091501300209633)
172. Taguchi A & White MF 2008 Insulin-like signaling, nutrient homeostasis, and life span. Annual Review of Physiology 70 191-212. (doi:10.1146/annurev.physiol.70.113006.100533)
173. Tamburini J, Chapuis N, Bardet V, Park S, Sujobert P, Willems L, Ifrah N, Dreyfus F, Mayeux P, Lacombe C et al. 2008 Mammalian target of rapamycin (mTOR) inhibition activates phosphatidylinositol 3-kinase/Akt by up-regulating insulin-like growth factor-1 receptor signaling in acute myeloid leukemia: rationale for therapeutic inhibition of both pathways. Blood 111 379-382. (doi:10.1182/blood-2007-03-080796)
174. Taniguchi CM, Emanuelli B & Kahn CR 2006 Critical nodes in signalling pathways: insights into insulin action. Nature Reviews. Molecular Cell Biology 7 85-96. (doi:10.1038/nrm1837)
175. Tennant MK, Thrasher JB, Twomey PA, Drivdahl RH, Birnbaum RS & Plymate SR 1996 Protein and messenger ribonucleic acid (mRNA) for the type 1 insulin-like growth factor (IGF) receptor is decreased and IGF-II mRNA is increased in human prostate carcinoma compared to benign prostate epithelium. Journal of Clinical Endocrinology and Metabolism 81 3774-3782. (doi:10.1210/jc.81.10.3774)
176. Thurlimann B, Keshaviah A, Coates AS, Mouridsen H, Mauriac L, Forbes JF, Paridaens R, Castiglione-Gertsch M, Gelber RD, Rabaglio M et al. 2005 A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer. New England Journal of Medicine 353 2747-2757. (doi:10.1056/ NEJMoa052258)
177. Tode B, Serio M, Rotella CM, Galli G, Franceschelli F, Tanini A & Toccafondi R 1989 Insulin-like growth factor-I: autocrine secretion by human thyroid follicular cells in primary culture. Journal of Clinical Endocrinology and Metabolism 69 639-647. (doi:10.1210/jcem-69-3-639)
178. Tran TT, Medline A & Bruce WR 1996 Insulin promotion of colon tumors in rats. Cancer Epidemiology, Biomarkers &Prevention 5 1013-1015. (Pubitemid 26415875)
179. Tricoli JV, Rall LB, Karakousis CP, Herrera L, Petrelli NJ, Bell GI & Shows TB 1986 Enhanced levels of insulin-like growth factor messenger RNA in human colon carcinomas and liposarcomas. Cancer Research 46 6169-6173. (Pubitemid 17221751)
180. Uhles S, Moede T, Leibiger B, Berggren PO & Leibiger IB 2003 Isoform-specific insulin receptor signaling involves different plasma membrane domains. Journal of Cell Biology 163 1327-1337. (doi:10.1083/jcb.200306093)
181. Vainio H, Kaaks R & Bianchini F 2002 Weight control and physical activity in cancer prevention: international evaluation of the evidence. European Journal of Cancer Prevention 11 (Supplement 2) S94-100.
182. Vella V, Sciacca L, Pandini G, Mineo R, Squatrito S, Vigneri R & Belfiore A 2001 The IGF system in thyroid cancer: new concepts. Molecular Pathology 54 121-124. (doi:10.1136/mp.54.3.121)
183. Vella V, Pandini G, Sciacca L, Mineo R, Vigneri R, PezzinoV &BelfioreA2002Anovel autocrine loop involving IGF-II and the insulin receptor isoform-A stimulates growth of thyroid cancer. Journal of Clinical Endocrinology and Metabolism 87 245-254. (doi:10.1210/jc.87.1.245)
184. Vicent D, Ilany J, Kondo T, Naruse K, Fisher SJ, Kisanuki YY, Bursell S, Yanagisawa M, King GL & Kahn CR 2003 The role of endothelial insulin signaling in the regulation of vascular tone and insulin resistance. Journal of Clinical Investigation 111 1373-1380. (doi:10.1172/JCI200315211)
185. Vigneri P, Frasca F, Sciacca L, Frittitta L & Vigneri R 2006 Obesity and cancer. Nutrition, Metabolism, and Cardiovascular Diseases 16 1-7. (doi:10.1016/j.numecd.2005.10.013)
186. Vigneri P, Frasca F, Sciacca L, Pandini G & Vigneri R 2009 Diabetes and cancer. Endocrine-Related Cancer 16 1103-1123. (doi:10.1677/ERC-09-0087)
187. Vogt B, Carrascosa JM, Ermel B, Ullrich A & Haring HU 1991 The two isotypes of the human insulin receptor (HIR-A and HIR-B) follow different internalization kinetics. Biochemical and Biophysical Research Communications 177 1013-1018. (doi:10.1016/0006-291X(91)90639-O)
188. Vrieling A, Voskuil DW, Bosma A, Majoor DM, van Doorn J, Cats A, Depla AC, Timmer R, Witteman BJ, Wesseling J et al. 2009 Expression of insulin-like growth factor system components in colorectal tissue and its relation with serum IGF levels. Growth Hormone & IGF Research 19 126-135. (doi:10.1016/j.ghir. 2008.08.004)
189. Werner H & Bruchim I 2009 The insulin-like growth factor-I receptor as an oncogene. Archives of Physiology and Biochemistry 115 58-71. (doi:10.1080/13813450902783106)
190. Wicha MS, Liu S & Dontu G 2006 Cancer stem cells: an old idea - a paradigm shift. Cancer Research 66 1883-1890 discussion 1895-1886. (doi:10.1158/0008-5472.CAN-05-3153)
191. Wu Y, Cui K, Miyoshi K, Hennighausen L, Green JE, Setser J, LeRoith D & Yakar S 2003 Reduced circulating insulin-like growth factor I levels delay the onset of chemically and genetically induced mammary tumors. Cancer Research 63 4384-4388. (Pubitemid 36951007)
192. Xu X, Dailey AB, Peoples-Sheps M, Talbott EO, Li N &Roth J 2009 Birth weight as a risk factor for breast cancer: a meta-analysis of 18 epidemiological studies. Journal of Women's Health 18 1169-1178. (doi:10.1089/jwh.2008.1034)
193. Yamaguchi Y, Flier JS, Benecke H, Ransil BJ & Moller DE 1993 Ligand-binding properties of the two isoforms of the human insulin receptor. Endocrinology 132 1132-1138. (doi:10.1210/en.132.3.1132)
194. Yan YP, Sailor KA, Vemuganti R & Dempsey RJ 2006 Insulin-like growth factor-1 is an endogenous mediator of focal ischemia-induced neural progenitor proliferation. European Journal of Neuroscience 24 45-54. (doi:10.1111/j.1460- 9568.2006.04872.x)
195. Yee D, Paik S, Lebovic GS, Marcus RR, Favoni RE, Cullen KJ, Lippman ME & Rosen N 1989 Analysis of insulin-like growth factor I gene expression in malignancy: evidence for a paracrine role in human breast cancer. Molecular Endocrinolgy 3 509-517. (doi:10.1210/mend-3-3-509)
196. Yee D, Morales FR, Hamilton TC & Von Hoff DD 1991 Expression of insulin-like growth factor I, its binding proteins, and its receptor in ovarian cancer. Cancer Research 51 5107-5112.
197. Zendehdel K, Nyren O, Ostenson CG, Adami HO, Ekbom A & Ye W 2003 Cancer incidence in patients with type 1 diabetes mellitus: a population-based cohort study in Sweden. Journal of National Cancer Institute 95 1797-1800. (doi:10.1093/jnci/djg105)
198. Zhang H, Pelzer AM, Kiang DT & Yee D 2007 Downregulation of type I insulin-like growth factor receptor increases sensitivity of breast cancer cells to insulin. Cancer Research 67 391-397. (doi:10.1158/0008-5472.CAN-06-1712)
199. Zhou HH, Chin CN, Wu M, NiW,Quan S, Liu F, Dallas-Yang Q, Ellsworth K, Ho T, Zhang A et al. 2009 Suppression of PC-1/ENPP-1 expression improves insulin sensitivity in vitro and in vivo. European Journal of Pharmacology 616 346-352. (doi:10.1016/j.ejphar.2009.06.057)